Treatment of prostate cancer: Watchful waiting, radical prostatectomy, and cryoablation

Seminars in Surgical Oncology

Volumn 18, Issue 1, 2000, Pages 37-44

  Drachenberg, Darrel E ^a,b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b NONE   (Canada)

Author keywords

Age factors; American Cancer Society; Bias; Biopsy; Cryosurgery; Hormonal antineoplastic agents; Impotence; Incidence; Mass screening; Mortality; Neoplasm staging; Patient selection; Postoperative complications; Prostate specific antigen; Prostatectomy; Prostatic neoplasms; Salvage therapy; SEER program; Survival rate; Time factors; Urinary incontinence

Indexed keywords

ANTINEOPLASTIC AGENT; HORMONE; PROSTATE SPECIFIC ANTIGEN;

BRACHYTHERAPY; CANCER HORMONE THERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; CONSERVATIVE TREATMENT; CRYOSURGERY; HUMAN; INTERMETHOD COMPARISON; MALE; PATIENT SELECTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; REVIEW; SALVAGE THERAPY;

EID: 0033986406     PISSN: 87560437     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1098-2388(200001/02)18:1<37::aid-ssu6>3.0.co;2-%23     Document Type: Review

References (66)

1. Landis SH, Murray T, Bolden S, Wingo PA: Cancer statistics, 1999. CA Cancer J Clin 1999;49:8-31.
2. Seidman H, Mushinski MH, Gelb SK, Silverberg E: Probabilities of eventually developing or dying of cancer - United States, 1985. CA Cancer J Clin 1985;35:36-56.
3. Carter HB, Coffey DS: The prostate: an increasing medical problem. Prostate 1990;16:39-48.
4. Silverberg E: Statistical and epidemiological data on urologie cancer [Review]. Cancer 1987;60(3 Suppl):692-717.
5. Meikle AW, Smith JA Jr: Epidemiology of prostate cancer [Review]. Urol Clin North Am 1990;17:709-718.
6. Mettlin CJ, Murphy GP, Babaian RJ, et al: Observations on the early detection of prostate cancer from the American Cancer Society National Prostate Cancer Detection Project. Cancer 1997;80:1814-1817.
7. Smart CR: The results of prostate carcinoma screening in the US as reflected in the Surveillance, Epidemiology, and End Results Program. Cancer 1997;80:1835-1844.
8. Standaert B, Denis L: The European Randomized Study of Screening for Prostate Cancer. An update. Cancer 1997;80:1830-1834.
9. Mettlin C, Jones G, Averette H, et al: Defining and updating the American Cancer Society guidelines for the cancer-related checkup: prostate and endometrial cancer. CA Cancer J Clin 1993;43:42-46.
10. Hall RR: Screening and early detection of prostate cancer will decrease morbidity and mortality from prostate cancer: the argument against [Review]. Eur Urol 1996;29 Suppl 2:24-26.
11. Matzkin H, Patel JP, Altwein JE, Soloway MS: Stage T1a carcinoma of the prostate [Review], Urology 1994;43:11-21.
12. Blute ML, Zincke H, Farrow GM: Long-term follow up of young patients with stage A adenocarcinoma of the prostate. J Urol 1986;136:840-843.
13. Epstein JI, Paull G, Eggleston JC, Walsh PC: Prognosis of untreated stage A1 prostatic carcinoma: a study of 94 cases with extended follow up. J Urol 1986;136:837-839.
14. Newling DW, Hall RR, Richards B: The natural history of prostatic cancer: the argument for no treatment policy. In: Pavone-Macaluso M (ed): "Testicular cancer and other tumors of the genitourinary tract." New York: Plenum Press; 1985. p. 443-449.
15. Moskovitz B, Nitecki S, Richter Levin D: Cancer of the prostate: is there a need for aggressive treatment? Urol Int 1987;42:49-52.
16. George NJ: Natural history of localized prostatic cancer managed by conservative therapy alone. Lancet 1988;1(8584):494-497.
17. Goodman CM, Busuttil A, Chisholm GD: Age, and size and grade of tumor predict prognosis in incidentally diagnosed carcinoma of the prostate. Br J Urol 1988;62:576-580.
18. Handley R, Carr TW, Travis D, et al: Deferred treatment for prostate cancer. Br J Urol 1988;62:249-253.
19. Orestano F: Problems of the wait-and-see policy in incidental carcinoma of the prostate. In: Altwein JE, Faul P, Schneider W (eds): "Incidental carcinoma of the prostate." Berlin: Springer-Verlag; 1991. p. 163-166.
20. Whitmore WF Jr, Warner JA, Thompson IM Jr: Expected management of localized prostatic cancer. Cancer 1991;67:1091-1096.
21. Adolfsson J, Carstensen J, Lowhagen T: Deferred treatment in clinically localized prostatic carcinoma. Br J Urol 1992;69:183-187.
22. Jones GW: Prospective, conservative management of localized prostate cancer. Cancer 1992; 70(1 Suppl):307-310.
23. Chodak GW, Thisted RA, Gerber GS, et al: Results of conservative management of clinically localized prostate cancer. N Engl J Med 1994; 330:242-248.
24. Albertsen PC, Fryback DG, Storer BE, et al: Long-term survival among men with conservatively treated localized prostate cancer. JAMA 1995;274:626-631.
25. Johansson JE, Holmberg L, Johansson S, et al: Fifteen-year survival in prostate cancer. A prospective, population-based study in Sweden [published erratum appears in JAMA 1997;278:206]. JAMA 1997;277:467-471.
26. Aus G, Hugosson J, Norlen L: Long-term survival and mortality in prostate cancer treated with noncurative intent [Review]. J Urol 1995; 154(2 Pt 1):460-465.
27. Wilt TJ, Brawer MK: The Prostate Cancer Intervention Versus Observation Trial (PIVOT) [Review]. Oncology 1997;1133-1140.
28. Pezzino G, Remington PL, Anderson HA, et al: Trends in the surgical treatment of prostate cancer in Wisconson, 1989-1991. J Natl Cancer Inst 1994;86:1083-1086.
29. Lu-Yao GL, McLerran D, Wasson J, Wennberg JE: An assessment of radical prostatectomy. Time trends, geographic variation, and outcomes. The Prostate Patient Outcomes Research Team. JAMA 1993;269:2633-2636.
30. Mettlin CJ, Murphy GP: Prostate cancer. In: Steele GD Jr, Winchester DP, Menck HR, Murphy GP (eds): "National cancer data base: annual review of cancer patient care 1993." Atlanta, GA: American Cancer Society; 1993. p. 37-51.
31. Mettlin C, Jones GW, Murphy GP: Trends in prostate cancer care in the United States, 1974-1990: observations from the patient care evaluation studies of the American College of Surgeons Commission on Cancer. CA Cancer J Clin 1993;43:83-91.
32. Epstein JI, Pizov G, Walsh PC: Correlation of pathologic findings with progression after radical retropubic prostatectomy. Cancer 1993;71:3582-3593.
33. Oesterling JE: Radical prostatectomy the retropubic approach [editorial]. Urology 1996;47:460-462.
34. Frazier HA, Robertson JE, Paulson DF: Radical prostatectomy: the pros and cons of perineal versus retropubic approach. J Urol 1992;147(3 Pt 2):888-890.
35. Weldon VE, Tavel FR, Neuwirth H, Cohen R: Patterns of positive specimen margins and detectable prostate specific antigen after radical perineal prostatectomy [published erratum appears in J Urol 1995;154(2 Pt 1):538]. J Urol 1995;153:1565-1569.
36. Resnick MI: Radical prostatectomy: the perineal approach [editorial]. Urology 1996;47:457-459.
37. Walther PJ: Radical perineal vs. retropubic prostatectomy: a review of optimal application and technical considerations in the utilization of these exposures. Eur Urol 1993;24 Suppl 2:34-38.
38. Walsh PC: Radical retropubic prostatectomy: indication, technique, and long-term results. In: Oesterling JE, Richie JP (eds): "Urologic oncology." Philadelphia: Saunders;1997. p. 147-161.
39. Pedersen KV, Herder A: Radical retropubic prostatectomy for localized prostatic carcinoma: a clinical and pathological study of 201 cases. Scand J Urol Nephrol 1993;27:219-224.
40. Davidson PJ, van den Ouden D, Schroeder FH: Radical prostatectomy: prospective assessment of mortality and morbidity. Eur Urol 1996;29:168-173.
41. Zincke H, Bergstralh EJ, Blute ML, et al: Radical prostatectomy for clinically localized prostate cancer: long-term results of 1,143 patients from a single institutions. J Clin Oncol 1994;12:2254-2263.
42. Dillioglugil O, Leibman BD, Leibman NS, et al: Risk factors for complications and morbidity after radical retropubic prostatectomy [Review]. J Urol 1997;157:1760-1767.
43. Gibbons RP, Correa RJ Jr, Brannen GE, Mason JT: Total prostatectomy for localized prostate cancer. J Urol 1984;131:73-76.
44. Walsh PC: Radical prostatectomy, preservation of sexual function, cancer control. The controversy [Review]. Urol Clin North Am 1987;14:663-673.
45. Lindner A, de Kernion JB, Smith RB, Katske FA: Risk of urinary incontinence following radical prostatectomy. J Urol 1983;129: 1007-1008.
46. Middleton RG, Smith JA Jr, Melzer RB, Hamilton PE: Patient survival and local recurrence rate following radical prostatectomy for prostatic carcinoma. J Urol 1986;136:422-424.
47. Igel TC, Barrett DM, Segura JW, et al: Perioperative and postoperative complications from bilateral pelvic lymphadenectomy and radical retropubic prostatectomy. J Urol 1987;137:1189-1191.
48. Zincke H, Oesterling JE, Blute ML, et al: Long-term (15 years) results after radical prostatectomy for clincally localized (stage T2c or lower) prostate cancer. J Urol 1994;152(5 Pt 2):1850-1857.
49. Leandri P, Rossignol G, Gautier JR, Ramon J: Radical retropubic prostatectomy: morbidity and quality of life. Experience with 620 consecutive cases. J Urol 1992;147(3 Pt 2):883-887.
50. Steiner MS, Morton RA, Walsh PC: Impact of anatomical radical prostatectomy on urinary continence. J Urol 1991;145:512-515.
51. Catalona WJ, Smith DS: Cancer recurrence and survival rates after anatomic radical retropubic prostatectomy for prostate cancer: intermediate-term results. J Urol 1998;160(6 Pt 2):2428-2434.
52. Gerber GS, Thisted RA, Scardino PT, et al: Results of radical prostatectomy in men with clinically localized prostate cancer. JAMA 1996;276:615-619.
53. Gonder MJ, Soanes WA, Smith V: Experimental prostate cryosurgery. Invest Urol 1964;1:610-619.
54. Soanes WA, Gonder MJ: Use of cryosurgery in prostatic cancer. J Urol 1968;99:793-797.
55. Onik G, Cobb C, Cohen J, et al: US characteristics of frozen prostate. Radiology 1988;168:629-631.
56. Weider J, Schmidt JD, Casola G, et al: Transrectal ultrasound-guided transperineal cryoablation in the treatment of prostate carcinoma: preliminary results [Review]. J Urol 1995;154(2 Pt 1): 435-441.
57. Cohen JK, Miller RJ Jr., Rooker GM, et al: Four-year PSA and biopsy results after cryosurgical ablation of the prostate for localized adenocarcinoma of the prostate [Abstract]. J Urol 1997; 157:419.
58. Cespedes RD, Pisters LL, von Eschenbach AC, McGuire EJ: Long-term follow up of incontinence and obstruction after salvage cryosurgical ablation of the prostate: results in 143 patients. J Urol 1997;157:237-240.
59. Lee F, Bahn DK, McHugh TA, et al: Cryosurgery of prostate cancer. Use of adjuvant hormonal therapy and temperature monitoring - A one year follow-up. Anticancer Res 1997;17:1511-1515.
60. Schmidt JD, Doyle J, Larison S: Prostate cryoablation: update 1998 [Review]. CA Cancer J Clin 1998;48:239-253.
61. Gould RS: New approaches to cryosurgery - comparisons to radical surgery [Abstract]. Br J Urol 1997;80(Suppl 2):269.
62. Chin JL, Downey DB, Mulligan M, et al: A new cryosurgery system for prostate cancer: Preliminary experience in non-surgical candidates [Abstract]. Br J Urol 1997;80(Suppl 2): 262.
63. Catalona WJ: Management of cancer of the prostate. N Engl J Med 1994;331:996-1004.
64. National Institutes of Health Consensus Development Conference on the Management of Clinically Localized Prostate Cancer. Bethesda, Maryland, June 15-17, 1987 [Review]. NCI Monogr 1988;(7):1-174.
65. Stamey TA, Donaldson AN, Yemoto CE, et al: Histologic and clinical findings in 896 consecutive prostates treated only with radical retropubic prostatectomy: epidemiologic significance of annual changes. J Urol 1998;160(6 Pt 2):2412-2417.
66. Middleton RG, Thompson IM, Austenfeld MS, et al: Prostate Cancer Clinical Guidelines Panel Summary report on the management of clinically localized prostate cancer. The American Urological Association. J Urol 1995;154:2144-2148.